Diabetes Education News

An automated insulin delivery system controlled by an artificial intelligence machine learning model may perform just as well as a system using a traditional equation-based insulin dosing algorithm, according to a speaker.

Susan Weiner, MS, RDN, CDCES, FADCES, talks with Katelyn O’Brien, PharmD, BCPS, CDCES, BC-ADM, about situations in which an ultra-long-acting insulin may be a good choice.

GLP-1 receptor agonists come with known adverse events — some common and some rare — but recent reports by the public of alopecia and suicidal ideation have the FDA investigating.

Along with type 2 diabetes, dyslipidemia and thrombosis, the cardiometabolic diseases of obesity, hypertension and heart disease form a complex triad that poses significant risks to the health of individuals.

Middle-aged adults who eat more plant-based foods and fewer animal-based products are less likely to develop incident diabetes, according to study findings published in Diabetes Care.

Bariatric surgery will continue to be a therapeutic option for obesity and early diabetes in the future and may be used in combination with newer medications, according to a speaker.

Providers should use both HbA1c values and continuous glucose monitoring data to manage diabetes and prevent complications, though HbA1c should remain the standard for diagnosing diabetes, according to two speakers.

Using a pod-based automated insulin delivery system can provide glycemic benefits for people with type 2 diabetes, according to a speaker at the International Conference on Advanced Technologies & Treatments for Diabetes.

A slew of new medications currently in development may allow health care providers to go beyond glycemic management in the treatment of type 2 diabetes, according to a speaker.

The FDA cleared for marketing an over-the-counter continuous glucose monitor for adults with or without diabetes, according to an agency press release.